MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
Insider trades, last 90 days
0 buys · 6 sells
- Sold $5.28M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
172
- +25 vs. Q1 2026
- Total value $1.43B
Superinvestors holding MLTX
0
- None of the superinvestors held MLTX at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MLTX insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 20264:10 PM ET | Jul 27, 2026 | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −1.1K | $20.00 | −$22K | 2.71M | 0.0% | SEC10b5-1 |
| Jul 23, 20264:05 PM ET | Jul 21 – Jul 22, 2026 | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −52.45K | $20.0191 | −$1.05M | 2.71M | −1.9% | SEC10b5-1 |
| Jul 21, 20266:13 PM ET | Jul 20, 2026 | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −43.7K | $20.09 | −$877.93K | 2.76M | −1.6% | SEC10b5-1 |
| Jul 20, 20266:07 AM ET | Jul 15, 2026 | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −16.11K | $20.01 | −$322.26K | 2.81M | −0.6% | SEC10b5-1 |
| Jul 13, 20264:10 PM ET | Jul 9 – Jul 10, 2026 | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −102.23K | $20.0167 | −$2.05M | 2.77M | −3.6% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MLTX at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF INC/IL | 16,001,284 | $311.54M | 7.97% | 00.0% | Unchanged |
| Deep Track Capital, LP | 6,999,025 | $136.27M | 2.01% | +590,162+9.2% | Added |
| T. Rowe Price Investment Management, Inc. | 4,280,624 | $83.34M | 0.05% | +4,280,624 | New |
| D. E. Shaw & Co., Inc. | 3,365,507 | $65.53M | 0.04% | +974,846+40.8% | Added |
| Cormorant Asset Management, LP | 3,205,433 | $62.41M | 3.20% | −1,275,000−28.5% | Reduced |